Govt brings 39 more drugs under price control ambit

Last Updated: Thursday, July 16, 2015, 15:07

In a statement, regulator National Pharmaceutical Pricing Authority (NPPA) said "it has fixed/revised the prices in respect of 39 formulation packs..."

AstraZeneca launches diabetes drug, stock up 20%

Last Updated: Thursday, June 11, 2015, 12:35

AstraZeneca Pharma on Thursday said it has launched diabetes drug 'Forxiga' in India.

AstraZeneca, Dr Reddy's ink diabetes drug distribution pact

Last Updated: Friday, May 29, 2015, 19:32

AstraZeneca Pharma India and Dr Reddy's Laboratories on Friday entered into a distribution agreement for two drugs -- Riax and Riax-M -- used for treatment of diabetes in India.

Glenmark gets USFDA nod for generic diabetes treatment drug

Last Updated: Friday, May 29, 2015, 12:49

Shares of Glenmark Pharmaceuticals were trading at Rs 874.75 per scrip in afternoon trade, up 2.04 percent from the previous close on the BSE.

High Court bars Glenmark from making anti-diabetes drugs

Last Updated: Friday, March 20, 2015, 17:34

The Delhi High Court on Friday restrained Indian firm Glenmark Pharmaceuticals from manufacturing, marketing or selling its anti-diabetes drugs Zita and Zita-Met, saying it has "prima facie" infringed the patent of US drug major Merck Sharp and Dohme (MSD).

Google tests prototype of diabetes-tracking ''smart'' contact lens

Last Updated: Friday, January 17, 2014, 07:12

Google Inc said on Thursday that it is testing a new method for diabetics to monitor their blood-sugar levels by wearing a contact lens equipped with tiny chips and an antenna.

Diabetes risk gene may have been inherited from Neanderthals

Last Updated: Thursday, December 26, 2013, 15:37

Researchers have found a new genetic clue that increased risk of developing Type 2 diabetes in Latin Americans.

Diabetes: A lifestyle disease

Last Updated: Thursday, October 24, 2013, 15:30

Certain genetic and lifestyle factors contribute to an increase in blood sugar levels.

Zydus gets USFDA nod for clinical trial anti-diabetes molecule

Last Updated: Wednesday, October 23, 2013, 15:10

Drug firm Cadila Healthcare today said the Zydus group has received approval from the US health regulator for initiating Phase I clinical trial for ZYDPLA1 - a new molecule aimed for diabetes treatment.